{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Skip Navigation
www.ahrq.gov
search
home
whatsnew
collection
primers
glossary
newsletter
mypsnet
newsletter
The Collection
>
Study
PATIENT SAFETY PRIMERS
The Collection
Narrow By
clear selections
Safety Target
•
Device-related Complications (68)
•
Diagnostic Errors (101)
•
Identification Errors (43)
•
Discontinuities, Gaps, and Hand-Off Problems (235)
•
Fatigue and Sleep Deprivation (45)
•
Medication Safety (801)
•
Medical Complications (214)
•
Nonsurgical Procedural Complications (30)
•
Surgical Complications (172)
•
Transfusion Complications (11)
•
Psychological and Social Complications (56)
Origin/Sponsor
•
Africa (3)
•
Asia (46)
•
Australia and New Zealand (53)
•
Central and South America (6)
•
Europe (210)
•
North America (1574)
Resource Types
< All
Study
Error Types
•
Epidemiology of Errors and Adverse Events (1133)
•
Active Errors (239)
•
Latent Errors (76)
•
Near Miss (57)
Approach to Improving Safety
•
Quality Improvement Strategies (332)
•
Legal and Policy Approaches (81)
•
Error Reporting and Analysis (811)
•
Communication Improvement (327)
•
Human Factors Engineering (129)
•
Teamwork (67)
•
Specialization of Care (124)
•
Logistical Approaches (155)
•
Culture of Safety (173)
•
Technologic Approaches (347)
•
Education and Training (245)
Clinical Areas
•
Allied Health Services (6)
•
Dentistry (1)
•
Medicine (1369)
•
Nursing (196)
•
Pharmacy (264)
Target Audience
•
Health Care Providers (1256)
•
Health Care Executives and Administrators (1454)
•
Non-Health Care Professionals (581)
•
Patients (19)
Setting of Care
•
Hospitals (1393)
•
Psychiatric Facilities (6)
•
Residential Facilities (43)
•
Ambulatory Care (254)
•
Outpatient Surgery (12)
•
Patient Transport (18)
1 - 20
of 1888
Show Excerpt
Don't Show Excerpt
Sort by relevance
Sort by significance
Sort by title
Sort by date
Sort by author
dropdown
STUDY
Provider and pharmacist responses to warfarin drug–drug interaction alerts: a study of healthcare downstream of CPOE alerts.
Miller AM, Boro MS, Korman NE, Davoren JB. J Am Med Inform Assoc. 2011;18(suppl 1):i45-i50.
STUDY
Ambulatory care adverse events and preventable adverse events leading to a hospital admission.
Woods DM, Thomas EJ, Holl JL, Weiss KB, Brennan TA. Qual Saf Health Care. 2007;16:127-131.
STUDY
Anticoagulation-associated adverse drug events.
Piazza G, Nguyen TN, Cios D, et al. Am J Med. 2011;124:1136-1142.
STUDY
Predictors of medication errors among elderly hospital patients.
Picone DM, Titler MG, Dochterman J, et al. Am J Med Qual. 2008;23:115-127.
STUDY
Medication errors associated with code situations in U.S. hospitals: direct and collateral damage.
Lipshutz AKM, Morlock LL, Shore AD, et al. Jt Comm J Qual Patient Saf. 2008;34:46-56.
STUDY
Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities.
Hansen RA, Cornell PY, Ryan PB, Williams CE, Pierson S, Greene SB. Pharmacoepidemiol Drug Saf. 2010;19:1087-1094.
STUDY
Antecedents of severe and nonsevere medication errors.
Chang YK, Mark BA. J Nurs Scholarsh. 2009;41:70-78.
STUDY
Pediatric medication errors in the postanesthesia care unit: analysis of MEDMARX data.
Payne CH, Smith CR, Newkirk LE, Hicks RW. AORN J. 2007;85:731-740.
STUDY
Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.
Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Ann Emerg Med. 2005;45:197-206.
STUDY
Adverse drug event reporting in intensive care units: a survey of current practices.
Kane-Gill SL, Devlin JW. Ann Pharmacother. 2006;40:1267-73.
STUDY
Adverse drug events resulting from patient errors in older adults.
Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. J Am Geriatr Soc. 2007;55:271-276.
STUDY
The safety of warfarin therapy in the nursing home setting.
Gurwitz JH, Field TS, Radford MJ, et al. Am J Med. 2007;120:539-544.
STUDY
Adopting real-time surveillance dashboards as a component of an enterprisewide medication safety strategy.
Waitman LR, Phillips IE, McCoy AB, et al. Jt Comm J Qual Patient Saf. 2011;37:326-332.
STUDY
Medication reconciliation for reducing drug-discrepancy adverse events.
Boockvar KS, Carlson Lacorte H, Giambanco V, Fridman B, Siu A. Am J Geriatr Pharmacother. 2006;4:236-243.
STUDY
Determinants of patient-reported medication errors: a comparison among seven countries.
Lu CY, Roughead E. Int J Clin Pract. 2011;65:733-740.
STUDY
Inter-rater reliability of a classification system for hospital adverse drug event reports.
Haynes K, Hennessy S, Morales KH, et al. Clin Pharmacol Ther. 2008;83:485-488.
STUDY
Drug errors and related interventions reported by United States clinical pharmacists: The American College of Clinical Pharmacy Practice-Based Research Network medication error detection, amelioration and prevention study.
Kuo GM, Touchette DR, Marinac JS; American College of Clinical Pharmacy Practice-Based Research Network Collaborative. Pharmacotherapy. 2013;33:253-265.
STUDY
Supratherapeutic dosing of acetaminophen among hospitalized patients.
Zhou L, Maviglia SM, Mahoney LM, et al. Arch Intern Med. 2012;172:1721-1728.
STUDY
Paid malpractice claims for adverse events in inpatient and outpatient settings.
Bishop TF, Ryan AK, Casalino LP. JAMA. 2011;305:2427-2431.
STUDY
Medication errors and response bias: the tip of the iceberg.
Bar-Oz B, Goldman M, Lahat E, et al. Isr Med Assoc J. 2008;10:771-774.
1
2
3
4
5
6
7
8
9
10
11
Next >